1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. The Company applys purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Its portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.

550 E Swedesford Rd Ste 400
Wayne, Pennsylvania 19087-1601
Phone: 16102256800


Teleflex Announces First Quarter 2024 Earnings Conference Call Information
Apr 18, 2024 10:30am

WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024.

TFX Expands Focus to Help Small Businesses
Apr 16, 2024 13:00pm

TFX, a top-rated US tax firm, announced the extension of its tax preparation services to cater to the needs of small businesses. NEW YORK, NY, USA, April 16, 2024 /⁨⁩/ -- Responding to the increasing demand for professional …

Source:EIN News Finance
Teleflex Incorporated Introduces the UroLift 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
Apr 02, 2024 10:30am

WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced Tissue Control (ATC) feature on its unified UroLift 2 System platform designed for the treatment of benign prostatic hyperplasia (BPH) symptoms in men with all prostate types up to 100g. The UroLift 2 Jetzt den vollständigen Artikel lesen

Teleflex Inc at Raymond James Institutional Investors Conference Transcript
Mar 07, 2024 19:31pm

Teleflex Inc at Raymond James Institutional Investors Conference Transcript

Truist Financial Lowers Teleflex (NYSE:TFX) Price Target to $265.00
Feb 25, 2024 10:28am

Teleflex (NYSE:TFX – Get Free Report) had its price target dropped by investment analysts at Truist Financial from $270.00 to $265.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “hold” rating on the medical technology company’s stock. Truist Financial’s price objective indicates a potential upside of 11.46% from the […]

Source:The AM Reporter
Decoding Teleflex Inc (TFX): A Strategic SWOT Insight
Feb 24, 2024 05:08am

Decoding Teleflex Inc (TFX): A Strategic SWOT Insight